5-flourouracil

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Advanced Solid TumoursCancer of Head and NeckSquamous Cell Cancer

Phase 1

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

CompletedNCT03421353

AstraZenecaAdvanced Solid Tumours

Start: 2018-02-07End: 2024-03-28Updated: 2024-08-21

Phase 2

The IRESSA Novel Head and Neck Chemotherapy Evaluation Study

CompletedNCT00255476

AstraZenecaCancer of Head and Neck, Squamous Cell Cancer

Start: 2004-02-29End: 2007-07-31Target: 64Updated: 2009-04-23

Related Papers

Abstract LB-105: Plasma exposure-target engagement biomarker analysis for danvatirsen after multiple dosing schedules and route of administrations in patients with advanced solid tumors

Cancer Research2020-08-15

Population pharmacokinetic analysis of danvatirsen supporting flat dosing switch.

2019-01-1910 citations